Recent Finacing
Recent Raise
Provista Diagnostics develops and commercializes proteomic, blood‑based diagnostic, prognostic, and monitoring tests for breast and gynecologic cancers and operates a CAP‑accredited, CLIA‑certified clinical lab serving pharmaceutical and biotechnology companies.
Focus Areas
Total Raised
Funding rounds